MORGAN STANLEY - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$710,762,387
-3.1%
6,977,833
-4.0%
0.07%0.0%
Q2 2023$733,154,797
+20.5%
7,265,431
+9.8%
0.07%
+10.8%
Q1 2023$608,530,983
+3.4%
6,614,466
+1.9%
0.06%
-3.0%
Q4 2022$588,609,281
+26.7%
6,488,196
+6.2%
0.07%
+6.3%
Q3 2022$464,459,000
-14.1%
6,110,503
-4.5%
0.06%
-10.0%
Q2 2022$540,890,000
+88.8%
6,398,786
+96.0%
0.07%
+79.5%
Q1 2022$286,415,000
-6.0%
3,263,976
-6.3%
0.04%
+2.6%
Q4 2021$304,714,000
+15.9%
3,483,649
+8.3%
0.04%
+8.6%
Q3 2021$263,003,000
-2.6%
3,215,979
+8.6%
0.04%
-2.8%
Q2 2021$270,066,000
+11.2%
2,959,961
+4.2%
0.04%0.0%
Q1 2021$242,772,000
-8.5%
2,840,099
+1.1%
0.04%
-12.2%
Q4 2020$265,253,000
+19.8%
2,808,993
+10.3%
0.04%
-4.7%
Q3 2020$221,361,000
-5.7%
2,545,548
-5.3%
0.04%
-17.3%
Q2 2020$234,836,000
-24.2%
2,688,755
-28.4%
0.05%
-38.1%
Q1 2020$309,675,000
+17.2%
3,755,914
+34.6%
0.08%
+37.7%
Q4 2019$264,198,000
+25.0%
2,790,144
+14.7%
0.06%
+8.9%
Q3 2019$211,379,000
-3.9%
2,432,441
+1.0%
0.06%
-5.1%
Q2 2019$219,999,000
-25.8%
2,409,368
-21.9%
0.06%
-29.8%
Q1 2019$296,433,000
+19.7%
3,083,363
+6.9%
0.08%
+13.5%
Q4 2018$247,578,000
-2.2%
2,885,187
-1.8%
0.07%
+17.5%
Q3 2018$253,191,000
+15.4%
2,938,605
+1.2%
0.06%
+6.8%
Q2 2018$219,362,000
-7.2%
2,903,909
-0.6%
0.06%
-10.6%
Q1 2018$236,303,000
+7.2%
2,922,721
+11.3%
0.07%
+10.0%
Q4 2017$220,455,000
+10.5%
2,625,726
+12.9%
0.06%0.0%
Q3 2017$199,595,000
+30.7%
2,324,931
+27.1%
0.06%
+30.4%
Q2 2017$152,714,000
-46.8%
1,829,567
-52.7%
0.05%
+4.5%
Q1 2017$287,260,000
+9.0%
3,867,786
+6.9%
0.04%
+2.3%
Q4 2016$263,602,000
+81.8%
3,618,930
+97.1%
0.04%
-14.0%
Q3 2016$145,012,000
-1.2%
1,836,516
+3.3%
0.05%
-5.7%
Q2 2016$146,745,000
+12.5%
1,778,497
-1.2%
0.05%
+6.0%
Q1 2016$130,383,000
-17.0%
1,799,870
-1.4%
0.05%
-12.3%
Q4 2015$157,085,000
-18.6%
1,825,725
-13.1%
0.06%
-19.7%
Q3 2015$193,010,000
-12.0%
2,099,760
-5.8%
0.07%
-6.6%
Q2 2015$219,271,000
+17.1%
2,229,718
+17.4%
0.08%
+10.1%
Q1 2015$187,235,000
-2.6%
1,898,730
-8.5%
0.07%
-1.4%
Q4 2014$192,222,000
+10.2%
2,074,495
+12.0%
0.07%
+4.5%
Q3 2014$174,427,000
+13.2%
1,853,023
+8.8%
0.07%
+11.7%
Q2 2014$154,134,000
-1.1%
1,702,578
-7.1%
0.06%
-7.7%
Q1 2014$155,886,000
-10.3%
1,833,516
-15.2%
0.06%
-12.2%
Q4 2013$173,817,000
+17.7%
2,162,446
+12.3%
0.07%
+5.7%
Q3 2013$147,665,000
-45.8%
1,924,978
-50.0%
0.07%
-48.9%
Q2 2013$272,459,0003,853,2080.14%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders